One phase 3 clinical trial found that survodutide led to an average 12% to 18.7% body weight reduction , depending on dose, in adults with obesity and without diabetes after 76 weeks compared to 5% in the placebo group
Questo prodotto in vendita dal 25/09/2017 Negli ultimi 30 giorni il prezzo pi basso del prodotto di 23,48
Nutrition, exercise, sleep, and lifestyle coaching are integrated into treatment
A significant reduction in the fear of self-injection from baseline to the end of the study was also reported [238]
Also, avoid excessive heat styling to preserve hair strength and prevent damage
At baseline, the average BMI was 31 kg/m2 and 81% had MetS